Safety, Tolerability, and Immunogenicity of a 21-Valent Pneumococcal Conjugate Vaccine, V116, in Healthy Adults: Phase 1/2, Randomised, Double-Blind, Active Comparator-Controlled, Multicentre, US-based Trial.
LANCET INFECTIOUS DISEASES（2023）
Key words
Pneumococcal Conjugate Vaccine
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined